| Year |
Citation |
Score |
| 2024 |
Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Antoniou AC, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243 |
0.366 |
|
| 2024 |
Saunders EJ, Dadaev T, Brook MN, Wakerell S, Govindasami K, Rageevakumar R, Hussain N, Osborne A, Keating D, Lophatananon A, Muir KR, Darst BF, Conti DV, Haiman CA, Antoniou AC, et al. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival. European Urology Oncology. PMID 38458890 DOI: 10.1016/j.euo.2024.02.003 |
0.325 |
|
| 2024 |
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, ... ... Antoniou AC, et al. Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction. Medrxiv : the Preprint Server For Health Sciences. PMID 38410445 DOI: 10.1101/2024.02.12.24302043 |
0.467 |
|
| 2024 |
Ho WK, Hassan NT, Yoon SY, Yang X, Lim JMC, Binte Ishak ND, Ho PJ, Wijaya EA, Ng PP, Luccarini C, Allen J, Tai MC, Chiang J, Zhang Z, See MH, ... ... Antoniou AC, et al. Age-specific breast and ovarian cancer risks associated with germline or pathogenic variants - an Asian study of 572 families. The Lancet Regional Health. Western Pacific. 44: 101017. PMID 38333895 DOI: 10.1016/j.lanwpc.2024.101017 |
0.506 |
|
| 2024 |
Bhatt R, van den Hout A, Antoniou AC, Shah M, Ficorella L, Steggall E, Easton DF, Pharoah PDP, Pashayan N. Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors. Cancer. PMID 38174903 DOI: 10.1002/cncr.35183 |
0.506 |
|
| 2023 |
Yang X, Kar S, Antoniou AC, Pharoah PDP. Polygenic scores in cancer. Nature Reviews. Cancer. PMID 37479830 DOI: 10.1038/s41568-023-00599-x |
0.387 |
|
| 2023 |
Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, Wang Q, Bolla MK, Dennis J, Michailidou K, Lush M, Ahearn T, Andrulis IL, Anton-Culver H, Antoniou AC, et al. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics. PMID 37451831 DOI: 10.1136/jmg-2023-109185 |
0.491 |
|
| 2023 |
van Barele M, Akdeniz D, Heemskerk-Gerritsen BAM, Andrieu N, Noguès C, van Asperen CJ, Wevers M, Ausems MGEM, de Bock GH, Dommering CJ, Gómez-García EB, van Leeuwen FE, Mooij TM, Easton DF, Antoniou AC, et al. Contralateral breast cancer risk in irradiated breast cancer patients with a germline-BRCA1/2 pathogenic variant. Journal of the National Cancer Institute. PMID 37369040 DOI: 10.1093/jnci/djad116 |
0.505 |
|
| 2023 |
Kast K, John EM, Hopper JL, Andrieu N, Noguès C, Mouret-Fourme E, Lasset C, Fricker JP, Berthet P, Mari V, Salle L, Schmidt MK, Ausems MGEM, Garcia EBG, van de Beek I, ... ... Antoniou AC, et al. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast Cancer Research : Bcr. 25: 72. PMID 37340476 DOI: 10.1186/s13058-023-01673-w |
0.454 |
|
| 2023 |
Archer S, Donoso FS, Carver T, Yue A, Cunningham AP, Ficorella L, Tischkowitz M, Easton DF, Antoniou AC, Emery J, Usher-Smith J, Walter FM. Exploring the barriers to and facilitators of implementing CanRisk in primary care: a qualitative thematic framework analysis. The British Journal of General Practice : the Journal of the Royal College of General Practitioners. PMID 37308304 DOI: 10.3399/BJGP.2022.0643 |
0.349 |
|
| 2023 |
Pillai D, Narayan J, Gentry-Maharaj A, Deo S, Vijaykumar DK, Mukherjee P, Wadhwa N, Bhasin A, Mishra A, Rajanbabu A, Kannan R, Husain Z, Kumar A, Antoniou AC, Manchanda R, et al. Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India. Cancers. 15. PMID 37296935 DOI: 10.3390/cancers15112973 |
0.364 |
|
| 2023 |
Muranen TA, Morra A, Khan S, Barnes DR, Bolla MK, Dennis J, Keeman R, Leslie G, Parsons MT, Wang Q, Ahearn TU, Aittomäki K, Andrulis IL, Arun BK, Behrens S, ... ... Antoniou AC, et al. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. Npj Breast Cancer. 9: 37. PMID 37173335 DOI: 10.1038/s41523-023-00546-x |
0.471 |
|
| 2023 |
O'Mahony DG, Ramus SJ, Southey MC, Meagher NS, Hadjisavvas A, John EM, Hamann U, Imyanitov EN, Andrulis IL, Sharma P, Daly MB, Hake CR, Weitzel JN, Jakubowska A, Godwin AK, ... ... Antoniou AC, et al. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. British Journal of Cancer. PMID 37076566 DOI: 10.1038/s41416-023-02263-5 |
0.363 |
|
| 2023 |
Allen I, Hassan H, Sofianopoulou E, Eccles D, Turnbull C, Tischkowitz M, Pharoah P, Antoniou AC. Risks of second non-breast primaries following breast cancer in women: a systematic review and meta-analysis. Breast Cancer Research : Bcr. 25: 18. PMID 36765408 DOI: 10.1186/s13058-023-01610-x |
0.499 |
|
| 2023 |
Usher-Smith JA, Hindmarch S, French DP, Tischkowitz M, Moorthie S, Walter FM, Dennison RA, Stutzin Donoso F, Archer S, Taylor L, Emery J, Morris S, Easton DF, Antoniou AC. Proactive breast cancer risk assessment in primary care: a review based on the principles of screening. British Journal of Cancer. 1-11. PMID 36737659 DOI: 10.1038/s41416-023-02145-w |
0.434 |
|
| 2023 |
Mavaddat N, Ficorella L, Carver T, Lee A, Cunningham AP, Lush M, Dennis J, Tischkowitz M, Downes K, Hu D, Hahnen E, Schmutzler RK, Stockley TL, Downs GS, Zhang T, ... ... Antoniou AC, et al. Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36649146 DOI: 10.1158/1055-9965.EPI-22-0756 |
0.527 |
|
| 2022 |
Nyberg T, Brook MN, Ficorella L, Lee A, Dennis J, Yang X, Wilcox N, Dadaev T, Govindasami K, Lush M, Leslie G, Lophatananon A, Muir K, Bancroft E, Easton DF, ... ... Antoniou AC, et al. CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201453. PMID 36493335 DOI: 10.1200/JCO.22.01453 |
0.359 |
|
| 2022 |
Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S, Ahmed M, Antoniou AC, Cleaver R, Dabir T, Evans DG, Golightly E, Jewell R, Kohut K, Manchanda R, et al. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: , , and . Journal of Medical Genetics. PMID 36411032 DOI: 10.1136/jmg-2022-108898 |
0.438 |
|
| 2022 |
Li S, MacInnis RJ, Lee A, Nguyen-Dumont T, Dorling L, Carvalho S, Dite GS, Shah M, Luccarini C, Wang Q, Milne RL, Jenkins MA, Giles GG, Dunning AM, Pharoah PDP, ... ... Antoniou AC, et al. Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction. American Journal of Human Genetics. 109: 1777-1788. PMID 36206742 DOI: 10.1016/j.ajhg.2022.09.006 |
0.447 |
|
| 2022 |
Li H, Engel C, Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, Radice P, Thomassen M, Hansen TVO, Gerdes AM, Nielsen HR, Caputo SM, Zambelli A, Borg A, Solano A, ... ... Antoniou AC, et al. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 24: 2208. PMID 36205748 DOI: 10.1016/j.gim.2022.08.005 |
0.519 |
|
| 2022 |
Hakkaart C, Pearson JF, Marquart L, Dennis J, Wiggins GAR, Barnes DR, Robinson BA, Mace PD, Aittomäki K, Andrulis IL, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Belhadj S, ... ... Antoniou AC, et al. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology. 5: 1061. PMID 36203093 DOI: 10.1038/s42003-022-03978-6 |
0.557 |
|
| 2022 |
Yang X, Eriksson M, Czene K, Lee A, Leslie G, Lush M, Wang J, Dennis J, Dorling L, Carvalho S, Mavaddat N, Simard J, Schmidt MK, Easton DF, Hall P, ... Antoniou AC, et al. Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. Journal of Medical Genetics. PMID 36162852 DOI: 10.1136/jmg-2022-108806 |
0.517 |
|
| 2022 |
Lee A, Mavaddat N, Cunningham A, Carver T, Ficorella L, Archer S, Walter FM, Tischkowitz M, Roberts J, Usher-Smith J, Simard J, Schmidt MK, Devilee P, Zadnik V, Jürgens H, ... ... Antoniou AC, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on , , updates to tumour pathology and cancer incidence. Journal of Medical Genetics. PMID 36162851 DOI: 10.1136/jmedgenet-2022-108471 |
0.556 |
|
| 2022 |
Allen I, Hassan H, Sofianopoulou E, Eccles D, Turnbull C, Tischkowitz M, Pharoah P, Antoniou AC. Risk of developing a second primary cancer in male breast cancer survivors: a systematic review and meta-analysis. British Journal of Cancer. PMID 36115878 DOI: 10.1038/s41416-022-01940-1 |
0.506 |
|
| 2022 |
Archer S, Fennell N, Colvin E, Laquindanum R, Mills M, Dennis R, Stutzin Donoso F, Gold R, Fan A, Downes K, Ford J, Antoniou AC, Kurian AW, Evans DG, Tischkowitz M. Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial. Cancers. 14. PMID 35681696 DOI: 10.3390/cancers14112716 |
0.432 |
|
| 2022 |
Gaba F, Oxley S, Liu X, Yang X, Chandrasekaran D, Kalsi J, Antoniou A, Side L, Sanderson S, Waller J, Ahmed M, Wallace A, Wallis Y, Menon U, Jacobs I, et al. Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews. Diagnostics (Basel, Switzerland). 12. PMID 35626184 DOI: 10.3390/diagnostics12051028 |
0.359 |
|
| 2022 |
Moorthie S, Babb de Villiers C, Burton H, Kroese M, Antoniou AC, Bhattacharjee P, Garcia-Closas M, Hall P, Schmidt MK. Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention. Preventive Medicine. 159: 107075. PMID 35526672 DOI: 10.1016/j.ypmed.2022.107075 |
0.494 |
|
| 2022 |
Ho PJ, Ho WK, Khng AJ, Yeoh YS, Tan BK, Tan EY, Lim GH, Tan SM, Tan VKM, Yip CH, Mohd-Taib NA, Wong FY, Lim EH, Ngeow J, Chay WY, ... ... Antoniou AC, et al. Overlap of high-risk individuals predicted by family history, and genetic and non-genetic breast cancer risk prediction models: implications for risk stratification. Bmc Medicine. 20: 150. PMID 35468796 DOI: 10.1186/s12916-022-02334-z |
0.471 |
|
| 2022 |
Fitzgerald RC, Antoniou AC, Fruk L, Rosenfeld N. The future of early cancer detection. Nature Medicine. 28: 666-677. PMID 35440720 DOI: 10.1038/s41591-022-01746-x |
0.325 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Antoniou AC, et al. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35314806 DOI: 10.1038/s41431-022-01085-y |
0.394 |
|
| 2022 |
Ang BH, Ho WK, Wijaya E, Kwan PY, Ng PS, Yoon SY, Hasan SN, Lim JMC, Hassan T, Tai MC, Allen J, Lee A, Taib NAM, Yip CH, Hartman M, ... ... Antoniou AC, et al. Predicting the Likelihood of Carrying a or Mutation in Asian Patients With Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101647. PMID 35143328 DOI: 10.1200/JCO.21.01647 |
0.434 |
|
| 2022 |
Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, Nielsen HR, Lee A, Yang X, McGuffog L, Parsons MT, Andrulis IL, Arnold N, Belotti M, Borg Å, ... ... Antoniou AC, et al. Cancer Risks Associated With and Pathogenic Variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102112. PMID 35077220 DOI: 10.1200/JCO.21.02112 |
0.52 |
|
| 2022 |
Schrijver LH, Mooij TM, Pijpe A, Sonke GS, Mourits MJE, Andrieu N, Antoniou AC, Easton DF, Engel C, Goldgar D, John EM, Kast K, Milne RL, Olsson H, Phillips KA, et al. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. Journal of the National Cancer Institute. PMID 35048954 DOI: 10.1093/jnci/djac004 |
0.445 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Antoniou AC, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7 |
0.406 |
|
| 2021 |
Nyberg T, Tischkowitz M, Antoniou AC. BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis. British Journal of Cancer. PMID 34963702 DOI: 10.1038/s41416-021-01675-5 |
0.411 |
|
| 2021 |
Ho WK, Tai MC, Dennis J, Shu X, Li J, Ho PJ, Millwood IY, Lin K, Jee YH, Lee SH, Mavaddat N, Bolla MK, Wang Q, Michailidou K, Long J, ... ... Antoniou AC, et al. Polygenic risk scores for prediction of breast cancer risk in Asian populations. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 34906514 DOI: 10.1016/j.gim.2021.11.008 |
0.499 |
|
| 2021 |
Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, Radice P, Thomassen M, Hansen TVO, Gerdes AM, Nielsen HR, Caputo SM, Zambelli A, Borg A, Solano A, ... ... Antoniou AC, et al. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 34906479 DOI: 10.1016/j.gim.2021.08.016 |
0.515 |
|
| 2021 |
Lee A, Yang X, Tyrer J, Gentry-Maharaj A, Ryan A, Mavaddat N, Cunningham AP, Carver T, Archer S, Leslie G, Kalsi J, Gaba F, Manchanda R, Gayther S, Ramus SJ, ... ... Antoniou AC, et al. Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors. Journal of Medical Genetics. PMID 34844974 DOI: 10.1136/jmedgenet-2021-107904 |
0.407 |
|
| 2021 |
Li SX, Milne RL, Nguyen-Dumont T, English DR, Giles GG, Southey MC, Antoniou AC, Lee A, Winship I, Hopper JL, Terry MB, MacInnis RJ. Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models. Cancers. 13. PMID 34680343 DOI: 10.3390/cancers13205194 |
0.462 |
|
| 2021 |
Pashayan N, Antoniou AC, Lee A, Wolfson M, Chiquette J, Eloy L, Eisen A, Stockley TL, Nabi H, Brooks JD, Dorval M, Easton DF, Knoppers BM, Chiarelli AM, Simard J. Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening? Journal of Personalized Medicine. 11. PMID 34575693 DOI: 10.3390/jpm11090916 |
0.372 |
|
| 2021 |
Ruiz de Garibay G, Fernandez-Garcia I, Mazoyer S, Leme de Calais F, Ameri P, Martinez-Ruiz SH, Damiola F, Barjhoux L, Thomassen M, Andersen LVB, Herranz C, Mateo F, Palomero L, Espin R, Gómez A, ... ... Antoniou AC, et al. Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants. Human Mutation. PMID 34420246 DOI: 10.1002/humu.24276 |
0.545 |
|
| 2021 |
Barnes DR, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arason A, Arnold N, Auber B, Azzollini J, ... ... Antoniou AC, et al. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. Journal of the National Cancer Institute. PMID 34320204 DOI: 10.1093/jnci/djab147 |
0.498 |
|
| 2021 |
Wolfson M, Gribble S, Pashayan N, Easton DF, Antoniou AC, Lee A, van Katwyk S, Simard J. Potential of polygenic risk scores for improving population estimates of women's breast cancer genetic risks. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 34230637 DOI: 10.1038/s41436-021-01258-y |
0.497 |
|
| 2021 |
Brooks JD, Nabi HH, Andrulis IL, Antoniou AC, Chiquette J, Després P, Devilee P, Dorval M, Droit A, Easton DF, Eisen A, Eloy L, Fienberg S, Goldgar D, Hahnen E, et al. Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I). Journal of Personalized Medicine. 11. PMID 34199804 DOI: 10.3390/jpm11060511 |
0.455 |
|
| 2021 |
Lakeman IMM, van den Broek AJ, Vos JAM, Barnes DR, Adlard J, Andrulis IL, Arason A, Arnold N, Arun BK, Balmaña J, Barrowdale D, Benitez J, Borg A, Caldés T, Caligo MA, ... ... Antoniou AC, et al. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 34113011 DOI: 10.1038/s41436-021-01198-7 |
0.559 |
|
| 2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, ... ... Antoniou AC, et al. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 2986. PMID 33990587 DOI: 10.1038/s41467-021-23162-4 |
0.515 |
|
| 2021 |
Li SX, Milne RL, Nguyen-Dumont T, Wang X, English DR, Giles GG, Southey MC, Antoniou AC, Lee A, Li S, Winship I, Hopper JL, Terry MB, MacInnis RJ. Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models. Jnci Cancer Spectrum. 5: pkab021. PMID 33977228 DOI: 10.1093/jncics/pkab021 |
0.521 |
|
| 2021 |
Ng PS, Pan JW, Ahmad Zabidi MM, Rajadurai P, Yip CH, Reuda OM, Dunning AM, Antoniou AC, Easton DF, Caldas C, Chin SF, Teo SH. Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses. Npj Breast Cancer. 7: 46. PMID 33893315 DOI: 10.1038/s41523-021-00254-4 |
0.343 |
|
| 2021 |
Ng PS, Boonen RA, Wijaya E, Chong CE, Sharma M, Knaup S, Mariapun S, Ho WK, Lim J, Yoon SY, Mohd Taib NA, See MH, Li J, Lim SH, Tan EY, ... ... Antoniou A, et al. Characterisation of protein-truncating and missense variants in in 15 768 women from Malaysia and Singapore. Journal of Medical Genetics. PMID 33811135 DOI: 10.1136/jmedgenet-2020-107471 |
0.428 |
|
| 2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, ... ... Antoniou AC, et al. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 1078. PMID 33597508 DOI: 10.1038/s41467-020-20496-3 |
0.493 |
|
| 2021 |
Pal Choudhury P, Brook MN, Hurson AN, Lee A, Mulder CV, Coulson P, Schoemaker MJ, Jones ME, Swerdlow AJ, Chatterjee N, Antoniou AC, Garcia-Closas M. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry. Breast Cancer Research : Bcr. 23: 22. PMID 33588869 DOI: 10.1186/s13058-021-01399-7 |
0.501 |
|
| 2021 |
Patel PS, Abraham KJ, Guturi KKN, Halaby MJ, Khan Z, Palomero L, Ho B, Duan S, St-Germain J, Algouneh A, Mateo F, El Ghamrasni S, Barbour H, Barnes DR, Beesley J, ... ... Antoniou AC, et al. RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors. The Journal of Clinical Investigation. 131. PMID 33529165 DOI: 10.1172/JCI140105 |
0.338 |
|
| 2021 |
Schrijver LH, Antoniou AC, Olsson H, Mooij TM, Roos-Blom MJ, Azarang L, Adlard J, Ahmed M, Barrowdale D, Davidson R, Donaldson A, Eeles R, Evans DG, Frost D, Henderson A, et al. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study. American Journal of Obstetrics and Gynecology. PMID 33493488 DOI: 10.1016/j.ajog.2021.01.014 |
0.46 |
|
| 2021 |
Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, ... ... Antoniou AC, et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. The New England Journal of Medicine. PMID 33471991 DOI: 10.1056/NEJMoa1913948 |
0.537 |
|
| 2020 |
Borde J, Ernst C, Wappenschmidt B, Niederacher D, Weber-Lassalle K, Schmidt G, Hauke J, Quante AS, Weber-Lassalle N, Horváth J, Pohl-Rescigno E, Arnold N, Rump A, Gehrig A, Hentschel J, ... ... Antoniou AC, et al. Performance of breast cancer polygenic risk scores in 760 female CHEK2 germline mutation carriers. Journal of the National Cancer Institute. PMID 33372680 DOI: 10.1093/jnci/djaa203 |
0.541 |
|
| 2020 |
Carver T, Hartley S, Lee A, Cunningham AP, Archer S, Babb de Villiers C, Roberts J, Ruston R, Walter FM, Tischkowitz M, Easton DF, Antoniou AC. CanRisk Tool - A web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33335023 DOI: 10.1158/1055-9965.EPI-20-1319 |
0.498 |
|
| 2020 |
Kramer I, Hooning MJ, Mavaddat N, Hauptmann M, Keeman R, Steyerberg EW, Giardiello D, Antoniou AC, Pharoah PDP, Canisius S, Abu-Ful Z, Andrulis IL, Anton-Culver H, Aronson KJ, Augustinsson A, et al. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. PMID 33022221 DOI: 10.1016/j.ajhg.2020.09.001 |
0.526 |
|
| 2020 |
Muranen TA, Khan S, Fagerholm R, Aittomäki K, Cunningham JM, Dennis J, Leslie G, McGuffog L, Parsons MT, Simard J, Slager S, Soucy P, Easton DF, Tischkowitz M, Spurdle AB, ... ... Antoniou AC, et al. Association of germline variation with the survival of women with pathogenic variants and breast cancer. Npj Breast Cancer. 6: 44. PMID 32964118 DOI: 10.1038/s41523-020-00185-6 |
0.433 |
|
| 2020 |
Ho WK, Tan MM, Mavaddat N, Tai MC, Mariapun S, Li J, Ho PJ, Dennis J, Tyrer JP, Bolla MK, Michailidou K, Wang Q, Kang D, Choi JY, Jamaris S, ... ... Antoniou AC, et al. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women. Nature Communications. 11: 3833. PMID 32737321 DOI: 10.1038/S41467-020-17680-W |
0.43 |
|
| 2020 |
Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, Mavaddat N, Adlard J, Ahmed M, Aittomäki K, Andrieu N, Andrulis IL, Arnold N, Arun BK, Azzollini J, ... ... Antoniou AC, et al. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32665703 DOI: 10.1038/S41436-020-0862-X |
0.568 |
|
| 2020 |
Lakeman IMM, Rodríguez-Girondo M, Lee A, Ruiter R, Stricker BH, Wijnant SRA, Kavousi M, Antoniou AC, Schmidt MK, Uitterlinden AG, van Rooij J, Devilee P. Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32624571 DOI: 10.1038/s41436-020-0884-4 |
0.528 |
|
| 2020 |
Palomero L, Galván-Femenía I, de Cid R, Espín R, Barnes DR, Cimba, Blommaert E, Gil-Gil M, Falo C, Stradella A, Ouchi D, Roso-Llorach A, Violan C, Peña-Chilet M, Dopazo J, ... ... Antoniou AC, et al. Immune Cell Associations with Cancer Risk. Iscience. 23: 101296. PMID 32622267 DOI: 10.1016/J.Isci.2020.101296 |
0.471 |
|
| 2020 |
Silvestri V, Leslie G, Barnes DR, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, ... ... Antoniou AC, et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Jama Oncology. PMID 32614418 DOI: 10.1001/Jamaoncol.2020.2134 |
0.49 |
|
| 2020 |
Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J, Garcia-Closas M, Schmutzler R, Wegwarth O, Pharoah P, et al. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature Reviews. Clinical Oncology. PMID 32601456 DOI: 10.1038/S41571-020-0412-0 |
0.375 |
|
| 2020 |
Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J, Garcia-Closas M, Schmutzler R, Wegwarth O, Pharoah P, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature Reviews. Clinical Oncology. PMID 32555420 DOI: 10.1038/S41571-020-0388-9 |
0.47 |
|
| 2020 |
Nyberg T, Frost D, Barrowdale D, Evans DG, Bancroft E, Adlard J, Ahmed M, Barwell J, Brady AF, Brewer C, Cook J, Davidson R, Donaldson A, Eason J, Gregory H, ... ... Antoniou AC, et al. Prostate Cancer Risk by BRCA2 Genomic Regions. European Urology. PMID 32532514 DOI: 10.1016/j.eururo.2020.05.005 |
0.405 |
|
| 2020 |
Gaba F, Blyuss O, Liu X, Goyal S, Lahoti N, Chandrasekaran D, Kurzer M, Kalsi J, Sanderson S, Lanceley A, Ahmed M, Side L, Gentry-Maharaj A, Wallis Y, Wallace A, ... ... Antoniou AC, et al. Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention. Cancers. 12. PMID 32429029 DOI: 10.3390/Cancers12051241 |
0.375 |
|
| 2020 |
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki K, ... ... Antoniou AC, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics. PMID 32424353 DOI: 10.1038/s41588-020-0609-2 |
0.471 |
|
| 2020 |
Archer S, Babb de Villiers C, Scheibl F, Carver T, Hartley S, Lee A, Cunningham AP, Easton DF, McIntosh JG, Emery J, Tischkowitz M, Antoniou AC, Walter FM. Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study. Plos One. 15: e0229999. PMID 32142536 DOI: 10.1371/journal.pone.0229999 |
0.452 |
|
| 2020 |
Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, Aittomäki K, Andrulis IL, Anton-Culver H, Antoniou AC, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genetic Epidemiology. PMID 32115800 DOI: 10.1002/gepi.22288 |
0.489 |
|
| 2020 |
Yang X, Song H, Leslie G, Engel C, Hahnen E, Auber B, Horváth J, Kast K, Niederacher D, Turnbull C, Houlston R, Hanson H, Loveday C, Dolinsky JS, LaDuca H, ... ... Antoniou AC, et al. Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D. Journal of the National Cancer Institute. PMID 32107557 DOI: 10.1093/Jnci/Djaa030 |
0.537 |
|
| 2020 |
Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA, Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A, Barrowdale D, Frost D, et al. Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 22: 25. PMID 32102695 DOI: 10.1186/S13058-020-01259-W |
0.532 |
|
| 2020 |
Saunders CL, Kilian B, Thompson DJ, McGeoch LJ, Griffin SJ, Antoniou AC, Emery JD, Walter FM, Dennis J, Yang X, Usher-Smith JA. External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using UK Biobank. Cancer Prevention Research (Philadelphia, Pa.). PMID 32071122 DOI: 10.1158/1940-6207.CAPR-19-0521 |
0.367 |
|
| 2020 |
Giardiello D, Antoniou AC, Mariani L, Easton DF, Steyerberg EW. Letter to the editor: a response to Ming's study on machine learning techniques for personalized breast cancer risk prediction. Breast Cancer Research : Bcr. 22: 17. PMID 32041655 DOI: 10.1186/s13058-020-1255-4 |
0.367 |
|
| 2020 |
Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA, Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A, Barrowdale D, Frost D, et al. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 22: 8. PMID 31948486 DOI: 10.1186/S13058-020-1247-4 |
0.542 |
|
| 2020 |
Glubb DM, Shi W, Beesley J, Fachal L, Pritchard JL, McCue K, Barnes DR, Antoniou AC, Dunning AM, Easton DF, Chenevix-Trench G. Candidate Causal Variants at the 8p12 Breast Cancer Risk Locus Regulate . Cancers. 12. PMID 31936698 DOI: 10.3390/cancers12010170 |
0.464 |
|
| 2020 |
Zheng Y, Hua X, Win AK, MacInnis RJ, Gallinger S, Le Marchand L, Lindor NM, Baron JA, Hopper JL, Dowty JG, Antoniou AC, Zheng J, Jenkins MA, Newcomb PA. A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31932410 DOI: 10.1158/1055-9965.Epi-19-0929 |
0.343 |
|
| 2020 |
Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, ... ... Antoniou AC, et al. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics. PMID 31911677 DOI: 10.1038/s41588-019-0537-1 |
0.358 |
|
| 2020 |
Beesley J, Sivakumaran H, Moradi Marjaneh M, Lima LG, Hillman KM, Kaufmann S, Tuano N, Hussein N, Ham S, Mukhopadhyay P, Kazakoff S, Lee JS, Michailidou K, Barnes DR, Antoniou AC, et al. Chromatin interactome mapping at 139 independent breast cancer risk signals. Genome Biology. 21: 8. PMID 31910858 DOI: 10.1186/s13059-019-1877-y |
0.428 |
|
| 2019 |
Phillips KA, Liao Y, Milne RL, MacInnis RJ, Collins IM, Buchsbaum R, Weideman PC, Bickerstaffe A, Nesci S, Chung WK, Southey MC, Knight JA, Whittemore AS, Dite GS, Goldgar D, ... ... Antoniou AC, et al. Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool. Jnci Cancer Spectrum. 3: pkz066. PMID 31853515 DOI: 10.1093/Jncics/Pkz066 |
0.469 |
|
| 2019 |
Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, ... ... Antoniou AC, et al. Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901907. PMID 31841383 DOI: 10.1200/Jco.19.01907 |
0.538 |
|
| 2019 |
Li H, Terry MB, Antoniou AC, Phillips KA, Kast K, Mooij TM, Engel C, Noguès C, Stoppa-Lyonnet D, Lasset C, Berthet P, Mari V, Caron O, Barrowdale D, Frost D, et al. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: results from The BRCA1 and BRCA2 Cohort Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31792088 DOI: 10.1158/1055-9965.Epi-19-0546 |
0.466 |
|
| 2019 |
Patel VL, Busch EL, Friebel TM, Cronin A, Leslie G, McGuffog L, Adlard J, Agata S, Agnarsson BA, Ahmed M, Aittomäki K, Alducci E, Andrulis IL, Arason A, Arnold N, ... ... Antoniou AC, et al. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. Cancer Research. PMID 31723001 DOI: 10.1158/0008-5472.Can-19-1840 |
0.395 |
|
| 2019 |
Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, Muranen TA, Barnes DR, Dennis J, Michailidou K, Bolla MK, Leslie G, Aalfs CM, ... ... Antoniou AC, et al. The :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. Npj Breast Cancer. 5: 38. PMID 31700994 DOI: 10.1038/s41523-019-0127-5 |
0.522 |
|
| 2019 |
Nyberg T, Frost D, Barrowdale D, Evans DG, Bancroft E, Adlard J, Ahmed M, Barwell J, Brady AF, Brewer C, Cook J, Davidson R, Donaldson A, Eason J, Gregory H, ... ... Antoniou AC, et al. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study. European Urology. PMID 31495749 DOI: 10.1016/j.eururo.2019.08.025 |
0.439 |
|
| 2019 |
Brédart A, Kop JL, Antoniou AC, Cunningham AP, De Pauw A, Tischkowitz M, Ehrencrona H, Schmidt MK, Dolbeault S, Rhiem K, Easton DF, Devilee P, Stoppa-Lyonnet D, Schmutzler R. Correction to: Clinicians' use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey. Journal of Community Genetics. PMID 31332717 DOI: 10.1007/s12687-019-00431-w |
0.505 |
|
| 2019 |
McGeoch L, Saunders CL, Griffin SJ, Emery JD, Walter FM, Thompson DJ, Antoniou AC, Usher-Smith JA. Risk prediction models for colorectal cancer incorporating common genetic variants: a systematic review. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31292139 DOI: 10.1158/1055-9965.EPI-19-0059 |
0.312 |
|
| 2019 |
Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, ... ... Antoniou AC, et al. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. PMID 31213659 DOI: 10.1038/S41416-019-0492-8 |
0.411 |
|
| 2019 |
Friebel TM, Andrulis IL, Balmaña J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, ... ... Antoniou AC, et al. BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry. Human Mutation. PMID 31112363 DOI: 10.1002/Humu.23804 |
0.331 |
|
| 2019 |
Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomäki K, Andrulis IL, Anton-Culver H, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Azzollini J, Balmaña J, Barnes DR, Barrowdale D, ... ... Antoniou AC, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications. 10: 1741. PMID 30988301 DOI: 10.1038/s41467-018-08053-5 |
0.5 |
|
| 2019 |
Spurdle AB, Greville-Heygate S, Antoniou AC, Brown M, Burke L, de la Hoya M, Domchek S, Dörk T, Firth HV, Monteiro AN, Mensenkamp A, Parsons MT, Radice P, Robson M, Tischkowitz M, et al. Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report. Journal of Medical Genetics. PMID 30962250 DOI: 10.1136/Jmedgenet-2018-105872 |
0.349 |
|
| 2019 |
Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, et al. A response to "Personalised medicine and population health: breast and ovarian cancer". Human Genetics. PMID 30810870 DOI: 10.1007/S00439-019-01984-Z |
0.333 |
|
| 2019 |
Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, de Villiers CB, Izquierdo A, Simard J, Schmidt MK, Walter FM, Chatterjee N, Garcia-Closas M, Tischkowitz M, Pharoah P, ... ... Antoniou AC, et al. Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 30787466 DOI: 10.1038/s41436-019-0459-4 |
0.436 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Antoniou AC, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.417 |
|
| 2019 |
Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S, Babb de Villiers C, Izquierdo A, Simard J, Schmidt MK, Walter FM, Chatterjee N, Garcia-Closas M, Tischkowitz M, Pharoah P, ... ... Antoniou AC, et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 30643217 DOI: 10.1038/s41436-018-0406-9 |
0.497 |
|
| 2019 |
Phillips K, Liao Y, Collins I, Buchsbaum R, Weideman P, Bickerstaffe A, MacInnis R, Cuzick J, Antoniou A, Andrulis I, John E, Daly M, Buys S, Hopper J, Terry M. Validation of iPrevent using the prospective family study cohort (ProF-SC) Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-09-02 |
0.406 |
|
| 2019 |
Choudhury PP, Wilcox A, Gao C, Carter B, Husing A, Brook M, Eriksson M, Martin K, Scott C, Shi M, Ahearn T, Jones M, Orr N, Schoemaker M, Czene K, ... ... Antoniou A, et al. Abstract 962: Validation of breast cancer risk model incorporating classical risk factors and polygenic risk scores in 14 prospective cohort studies in 6 countries Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-962 |
0.466 |
|
| 2018 |
Schrijver LH, Olsson H, Phillips KA, Terry MB, Goldgar DE, Kast K, Engel C, Mooij TM, Adlard J, Barrowdale D, Davidson R, Eeles R, Ellis S, Evans DG, Frost D, ... ... Antoniou AC, et al. Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study. Jnci Cancer Spectrum. 2: pky023. PMID 31360853 DOI: 10.1093/Jncics/Pky023 |
0.546 |
|
| 2018 |
Terry MB, Liao Y, Kast K, Antoniou AC, McDonald JA, Mooij TM, Engel C, Nogues C, Buecher B, Mari V, Moretta-Serra J, Gladieff L, Luporsi E, Barrowdale D, Frost D, et al. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With or Mutations. Jnci Cancer Spectrum. 2: pky078. PMID 30873510 DOI: 10.1093/Jncics/Pky078 |
0.464 |
|
| 2018 |
Lo LL, Collins IM, Bressel M, Butow P, Emery J, Keogh L, Weideman P, Steel E, Hopper JL, Trainer AH, Mann GB, Bickerstaffe A, Antoniou AC, Cuzick J, Phillips KA. The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing. Jmir Formative Research. 2: e24. PMID 30684421 DOI: 10.2196/formative.9935 |
0.484 |
|
| 2018 |
Cline MS, Liao RG, Parsons MT, Paten B, Alquaddoomi F, Antoniou A, Baxter S, Brody L, Cook-Deegan R, Coffin A, Couch FJ, Craft B, Currie R, Dlott CC, Dolman L, et al. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. Plos Genetics. 14: e1007752. PMID 30586411 DOI: 10.1371/Journal.Pgen.1007752 |
0.391 |
|
| 2018 |
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, ... ... Antoniou AC, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. PMID 30554720 DOI: 10.1016/J.Ajhg.2018.11.002 |
0.519 |
|
| 2018 |
Nyberg T, Govindasami K, Leslie G, Dadaev T, Bancroft E, Ni Raghallaigh H, Brook MN, Hussain N, Keating D, Lee A, McMahon R, Morgan A, Mullen A, Osborne A, Rageevakumar R, ... ... Antoniou AC, et al. Homeobox B13 G84E Mutation and Prostate Cancer Risk. European Urology. PMID 30527799 DOI: 10.1016/j.eururo.2018.11.015 |
0.349 |
|
| 2018 |
Hopper JL, Dite GS, MacInnis RJ, Liao Y, Zeinomar N, Knight JA, Southey MC, Milne RL, Chung WK, Giles GG, Genkinger JM, McLachlan SA, Friedlander ML, Antoniou AC, Weideman PC, et al. Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC). Breast Cancer Research : Bcr. 20: 132. PMID 30390716 DOI: 10.1186/S13058-018-1056-1 |
0.438 |
|
| 2018 |
Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... ... Antoniou AC, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132 |
0.529 |
|
| 2018 |
Walker LC, Marquart L, Pearson JF, Wiggins GAR, O'Mara TA, Parsons MT, Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D, ... ... Antoniou AC, et al. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. European Journal of Human Genetics : Ejhg. PMID 30135485 DOI: 10.1038/s41431-018-0216-1 |
0.479 |
|
| 2018 |
Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, Chen YA, Permuth JB, Reid BM, Teer JK, Moysich KB, Andrulis IL, Anton-Culver H, Arun BK, ... ... Antoniou AC, et al. A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. Cancer Research. PMID 30054336 DOI: 10.1158/0008-5472.Can-18-0951 |
0.335 |
|
| 2018 |
Yang X, Leslie G, Gentry-Maharaj A, Ryan A, Intermaggio M, Lee A, Kalsi JK, Tyrer J, Gaba F, Manchanda R, Pharoah PDP, Gayther SA, Ramus SJ, Jacobs I, Menon U, ... Antoniou AC, et al. Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study. Journal of Medical Genetics. PMID 29730597 DOI: 10.1136/jmedgenet-2018-105313 |
0.4 |
|
| 2018 |
Girardi F, Barnes DR, Barrowdale D, Frost D, Brady AF, Miller C, Henderson A, Donaldson A, Murray A, Brewer C, Pottinger C, Evans DG, Eccles D, Lalloo F, ... ... Antoniou AC, et al. Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 29565421 DOI: 10.1038/gim.2018.44 |
0.487 |
|
| 2018 |
Brédart A, Kop JL, Antoniou AC, Cunningham AP, De Pauw A, Tischkowitz M, Ehrencrona H, Schmidt MK, Dolbeault S, Rhiem K, Easton DF, Devilee P, Stoppa-Lyonnet D, Schmutlzer R. Clinicians' use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey. Journal of Community Genetics. PMID 29508368 DOI: 10.1007/s12687-018-0362-8 |
0.448 |
|
| 2018 |
Colombo M, Lòpez-Perolio I, Meeks HD, Caleca L, Parsons M, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, ... ... Antoniou AC, et al. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Human Mutation. PMID 29460995 DOI: 10.1002/humu.23411 |
0.448 |
|
| 2018 |
Andrews KA, Ascher DB, Pires DEV, Barnes DR, Vialard L, Casey RT, Bradshaw N, Adlard J, Aylwin S, Brennan P, Brewer C, Cole T, Cook JA, Davidson R, Donaldson A, ... ... Antoniou AC, et al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. Journal of Medical Genetics. PMID 29386252 DOI: 10.1136/jmedgenet-2017-105127 |
0.302 |
|
| 2018 |
Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, MacInnis RJ, Turnbull C, Ramus SJ, Gayther SA, Pharoah PDP, Menon U, Jacobs I, Legood R. Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women. Journal of the National Cancer Institute. PMID 29361001 DOI: 10.1093/jnci/djx265 |
0.335 |
|
| 2018 |
Van den Broek A, Robson M, Vos J, Bernstein J, Offit K, Rookus M, Chenevix-Trench G, Easton D, Antoniou A, Schmidt M. The association between Polygenic Risk Scores and contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: Analyses in the CIMBA consortium European Journal of Cancer. 92: S10. DOI: 10.1016/s0959-8049(18)30269-7 |
0.566 |
|
| 2017 |
Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, ... ... Antoniou AC, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. PMID 29059683 DOI: 10.1038/Nature24284 |
0.543 |
|
| 2017 |
Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, ... ... Antoniou AC, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. PMID 29058716 DOI: 10.1038/Ng.3785 |
0.553 |
|
| 2017 |
Wen WX, Allen J, Lai KN, Mariapun S, Hasan SN, Ng PS, Lee DS, Lee SY, Yoon SY, Lim J, Lau SY, Decker B, Pooley K, Dorling L, Luccarini C, ... ... Antoniou AC, et al. Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia. Journal of Medical Genetics. PMID 28993434 DOI: 10.1136/Jmedgenet-2017-104947 |
0.47 |
|
| 2017 |
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama. 317: 2402-2416. PMID 28632866 DOI: 10.1001/Jama.2017.7112 |
0.551 |
|
| 2017 |
Brédart A, Kop JL, Antoniou AC, Cunningham AP, De Pauw A, Tischkowitz M, Ehrencrona H, Dolbeault S, Robieux L, Rhiem K, Easton DF, Devilee P, Stoppa-Lyonnet D, Schmutlzer R. Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries. Familial Cancer. PMID 28623477 DOI: 10.1007/s10689-017-0014-x |
0.304 |
|
| 2017 |
Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... ... Antoniou AC, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935 |
0.545 |
|
| 2017 |
Dite GS, MacInnis RJ, Bickerstaffe A, Dowty JG, Milne RL, Antoniou AC, Weideman P, Apicella C, Giles GG, Southey MC, Jenkins MA, Phillips KA, Win AK, Terry MB, Hopper JL. Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer. American Journal of Epidemiology. 185: 487-500. PMID 28399571 DOI: 10.1093/Aje/Kww241 |
0.504 |
|
| 2017 |
Kuchenbaecker KB, McGuffog L, Barrowdale D, Lee A, Soucy P, Dennis J, Domchek SM, Robson M, Spurdle AB, Ramus SJ, Mavaddat N, Terry MB, Neuhausen SL, Schmutzler RK, Simard J, ... ... Antoniou AC, et al. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute. 109. PMID 28376175 DOI: 10.1093/Jnci/Djw302 |
0.562 |
|
| 2017 |
Walker LC, Marquart L, Pearson JF, Wiggins GA, O'Mara TA, Parsons MT, Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D, ... ... Antoniou AC, et al. Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. European Journal of Human Genetics : Ejhg. PMID 28145423 DOI: 10.1038/Ejhg.2016.203 |
0.541 |
|
| 2017 |
Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ. Abstract PR10: Development of a comprehensive colorectal cancer risk prediction tool (CRiPT) incorporating known and unknown major genes and polygenes Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-Pr10 |
0.495 |
|
| 2017 |
Schrijver LH, Olsson H, Antoniou A, Milne R, Phillips K, Andrieu N, Easton D, Goldgar D, Engel C, Kast K, Blom M, Mooij T, Hopper J, Leeuwen FV, Terry M, et al. Abstract 4276: Oral contraceptive use and breast cancer risk: a cohort study ofBRCA1andBRCA2mutation carriers Epidemiology. 77: 4276-4276. DOI: 10.1158/1538-7445.Am2017-4276 |
0.554 |
|
| 2016 |
Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, et al. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27799157 DOI: 10.1158/1055-9965.Epi-16-0693 |
0.334 |
|
| 2016 |
Hamdi Y, Soucy P, Kuchenbaeker KB, Pastinen T, Droit A, Lemaçon A, Adlard J, Aittomäki K, Andrulis IL, Arason A, Arnold N, Arun BK, Azzollini J, Bane A, Barjhoux L, ... ... Antoniou AC, et al. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Research and Treatment. PMID 27796716 DOI: 10.1007/S10549-016-4018-2 |
0.565 |
|
| 2016 |
Amos CI, Dennis J, Wang Z, Byun J, Schumacher FR, Gayther SA, Casey G, Hunter DJ, Sellers TA, Gruber SB, Dunning AM, Michailidou K, Fachal L, Doheny K, Spurdle AB, ... ... Antoniou AC, et al. The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27697780 DOI: 10.1158/1055-9965.Epi-16-0106 |
0.309 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... ... Antoniou AC, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.434 |
|
| 2016 |
Milne RL, Antoniou A. Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers. Endocrine-Related Cancer. PMID 27528622 DOI: 10.1530/ERC-16-0277 |
0.558 |
|
| 2016 |
Lee AJ, Cunningham AP, Tischkowitz M, Simard J, Pharoah PD, Easton DF, Antoniou AC. Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27464310 DOI: 10.1038/gim.2016.31 |
0.533 |
|
| 2016 |
Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Andrulis IL, Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen A, Bonanni B, Brewer C, Caldes T, ... ... Antoniou AC, et al. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Plos One. 11: e0158801. PMID 27463617 DOI: 10.1371/Journal.Pone.0158801 |
0.482 |
|
| 2016 |
Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, ... ... Antoniou AC, et al. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Research : Bcr. 18: 64. PMID 27459855 DOI: 10.1186/S13058-016-0718-0 |
0.453 |
|
| 2016 |
Manchanda R, Legood R, Antoniou AC, Gordeev VS, Menon U. Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis. Journal of Medical Genetics. PMID 27354448 DOI: 10.1136/jmedgenet-2016-103800 |
0.39 |
|
| 2016 |
Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, van den Ouweland A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, ... Antoniou AC, et al. Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269948 DOI: 10.1200/Jco.2016.66.5844 |
0.52 |
|
| 2016 |
Kurian AW, Antoniou AC, Domchek SM. Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 35: 44-56. PMID 27249685 DOI: 10.14694/EDBK_158817 |
0.505 |
|
| 2016 |
Li H, Feng B, Miron A, Chen X, Beesley J, Bimeh E, Barrowdale D, John EM, Daly MB, Andrulis IL, Buys SS, Kraft P, Thorne H, Chenevix-Trench G, ... ... Antoniou AC, et al. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27171545 DOI: 10.1038/Gim.2016.43 |
0.505 |
|
| 2016 |
Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, ... ... Antoniou AC, et al. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. 7: 11375. PMID 27117709 DOI: 10.1038/Ncomms11375 |
0.493 |
|
| 2016 |
Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Dennis J, Lush M, Milne RL, Shu XO, Beesley J, Kar S, Andrulis IL, Anton-Culver H, ... ... Antoniou AC, et al. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer. PMID 27087578 DOI: 10.1002/Ijc.30150 |
0.389 |
|
| 2016 |
Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, Kar S, Pooley KA, Lopez-Knowles E, Dicks E, Barrowdale D, Sinnott-Armstrong NA, Sallari RC, Hillman KM, ... ... Antoniou AC, et al. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics. PMID 26928228 DOI: 10.1038/Ng.3521 |
0.35 |
|
| 2016 |
Collins IM, Bickerstaffe A, Ranaweera T, Maddumarachchi S, Keogh L, Emery J, Mann GB, Butow P, Weideman P, Steel E, Trainer A, Bressel M, Hopper JL, Cuzick J, Antoniou AC, et al. iPrevent(®): a tailored, web-based, decision support tool for breast cancer risk assessment and management. Breast Cancer Research and Treatment. 156: 171-82. PMID 26909793 DOI: 10.1007/s10549-016-3726-y |
0.45 |
|
| 2016 |
Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, ... ... Antoniou AC, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 18: 15. PMID 26857456 DOI: 10.1186/S13058-016-0671-Y |
0.491 |
|
| 2016 |
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... ... Antoniou AC, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315 |
0.548 |
|
| 2015 |
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B, Esko T, Johnson AD, Elks CE, Franceschini N, He C, ... ... Antoniou AC, et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nature Genetics. PMID 26414677 DOI: 10.1097/01.Ogx.0000473766.71624.99 |
0.467 |
|
| 2015 |
Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP, Fraser L, Gentry-Maharaj A, Hayward J, Philpott S, Anderson C, Edlund CK, Conti D, Harrington P, Barrowdale D, ... ... Antoniou AC, et al. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. Journal of the National Cancer Institute. 107. PMID 26315354 DOI: 10.1093/Jnci/Djv214 |
0.401 |
|
| 2015 |
Antoniou AC, Foulkes WD, Tischkowitz M. Breast cancer risk in women with PALB2 mutations in different populations. The Lancet. Oncology. 16: e375-6. PMID 26248842 DOI: 10.1016/S1470-2045(15)00002-9 |
0.507 |
|
| 2015 |
Jervis S, Song H, Lee A, Dicks E, Harrington P, Baynes C, Manchanda R, Easton DF, Jacobs I, Pharoah PP, Antoniou AC. A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. Journal of Medical Genetics. 52: 465-75. PMID 26025000 DOI: 10.1136/Jmedgenet-2015-103077 |
0.42 |
|
| 2015 |
Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, et al. Gene-panel sequencing and the prediction of breast-cancer risk. The New England Journal of Medicine. 372: 2243-57. PMID 26014596 DOI: 10.1056/Nejmsr1501341 |
0.519 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.503 |
|
| 2015 |
Blein S, Bardel C, Danjean V, McGuffog L, Healey S, Barrowdale D, Lee A, Dennis J, Kuchenbaecker KB, Soucy P, Terry MB, Chung WK, Goldgar DE, Buys SS, ... ... Antoniou AC, et al. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 17: 61. PMID 25925750 DOI: 10.1186/S13058-015-0567-2 |
0.457 |
|
| 2015 |
Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985 |
0.544 |
|
| 2015 |
Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, et al. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1121-9. PMID 25837820 DOI: 10.1158/1055-9965.Epi-14-0317 |
0.355 |
|
| 2015 |
Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, Librado P, Sánchez-Gracia A, Rozas J, Bonifaci N, McGuffog L, Pankratz VS, Islam A, Mateo F, Berenguer A, ... ... Antoniou AC, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. Plos One. 10: e0120020. PMID 25830658 DOI: 10.1371/Journal.Pone.0120020 |
0.528 |
|
| 2015 |
Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Couch FJ, Offit K, Chenevix-Trench G, ... ... Antoniou A, et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24: 3595-607. PMID 25804953 DOI: 10.1093/Hmg/Ddv101 |
0.329 |
|
| 2015 |
Phillips KA, Steel EJ, Collins I, Emery J, Pirotta M, Mann GB, Butow P, Hopper JL, Trainer A, Moreton J, Antoniou AC, Cuzick J, Keogh L. Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease? Australian Journal of Primary Health. PMID 25705982 DOI: 10.1071/PY14156 |
0.409 |
|
| 2015 |
Kote-Jarai Z, Mikropoulos C, Leongamornlert DA, Dadaev T, Tymrakiewicz M, Saunders EJ, Jones M, Jugurnauth-Little S, Govindasami K, Guy M, Hamdy FC, Donovan JL, Neal DE, Lane JA, Dearnaley D, ... ... Antoniou AC, et al. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 756-61. PMID 25595936 DOI: 10.1093/annonc/mdv004 |
0.342 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Antoniou AC, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.471 |
|
| 2015 |
Castro E, Goh C, Leongamornlert D, Saunders E, Tymrakiewicz M, Dadaev T, Govindasami K, Guy M, Ellis S, Frost D, Bancroft E, Cole T, Tischkowitz M, Kennedy MJ, Eason J, ... ... Antoniou AC, et al. Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer. European Urology. 68: 186-93. PMID 25454609 DOI: 10.1016/j.eururo.2014.10.022 |
0.305 |
|
| 2015 |
Candido-dos-Reis FJ, Song H, Goode EL, Cunningham JM, Fridley BL, Larson MC, Alsop K, Dicks E, Harrington P, Ramus SJ, de Fazio A, Mitchell G, Fereday S, Bolton KL, Gourley C, ... ... Antoniou A, et al. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 652-7. PMID 25398451 DOI: 10.1158/1078-0432.Ccr-14-2497 |
0.377 |
|
| 2015 |
Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, ... ... Antoniou AC, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 308-16. PMID 25336561 DOI: 10.1158/1055-9965.Epi-14-0532 |
0.539 |
|
| 2015 |
Lawrenson K, Kar S, Kuckenbaeker K, Edwards S, Li Q, Tyrer J, Beesley J, Michailidou K, Ramus S, Dunning A, Couch F, Monteiro A, Simard J, Freedman M, Easton D, ... ... Antoniou A, et al. Abstract 2783: Common functional mechanisms underlying pleiotropy at the 19p13.1 breast and ovarian cancer cusceptibility locus Cancer Research. 75: 2783-2783. DOI: 10.1158/1538-7445.Am2015-2783 |
0.495 |
|
| 2015 |
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B, Esko T, Johnson AD, Elks CE, Franceschini N, He C, ... ... Antoniou AC, et al. Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair Obstetrical and Gynecological Survey. 70: 758-762. DOI: 10.1097/01.ogx.0000473766.71624.99 |
0.346 |
|
| 2014 |
Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, ... ... Antoniou AC, et al. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 16: 3416. PMID 25919761 DOI: 10.1186/S13058-014-0492-9 |
0.451 |
|
| 2014 |
Spurdle AB, Couch FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, ... ... Antoniou AC, et al. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research : Bcr. 16: 3419. PMID 25857409 DOI: 10.1186/S13058-014-0474-Y |
0.388 |
|
| 2014 |
Antoniou AC, Foulkes WD, Tischkowitz M. Breast-cancer risk in families with mutations in PALB2. The New England Journal of Medicine. 371: 1651-2. PMID 25337756 DOI: 10.1056/NEJMc1410673 |
0.536 |
|
| 2014 |
Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkäs K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomäki K, et al. Breast-cancer risk in families with mutations in PALB2. The New England Journal of Medicine. 371: 497-506. PMID 25099575 DOI: 10.1097/Ogx.0000000000000118 |
0.551 |
|
| 2014 |
Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, Butow P, Pirotta M, Antoniou AC, Cuzick J, Hopper J, Phillips KA, Keogh LA. Assessing and managing breast cancer risk: clinicians' current practice and future needs. Breast (Edinburgh, Scotland). 23: 644-50. PMID 24998452 DOI: 10.1016/j.breast.2014.06.014 |
0.378 |
|
| 2014 |
Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, DÃez O, Ramón Y Cajal T, Konstantopoulou I, MartÃnez-Bouzas C, Andrés Conejero R, ... ... Antoniou AC, et al. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. Plos Genetics. 10: e1004256. PMID 24698998 DOI: 10.1371/Journal.Pgen.1004256 |
0.51 |
|
| 2014 |
Pooley KA, McGuffog L, Barrowdale D, Frost D, Ellis SD, Fineberg E, Platte R, Izatt L, Adlard J, Bardwell J, Brewer C, Cole T, Cook J, Davidson R, Donaldson A, ... ... Antoniou AC, et al. Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1018-24. PMID 24642354 DOI: 10.1158/1055-9965.EPI-13-0635-T |
0.536 |
|
| 2014 |
Leongamornlert D, Saunders E, Dadaev T, Tymrakiewicz M, Goh C, Jugurnauth-Little S, Kozarewa I, Fenwick K, Assiotis I, Barrowdale D, Govindasami K, Guy M, Sawyer E, Wilkinson R, Antoniou AC, et al. Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease British Journal of Cancer. 110: 1663-1672. PMID 24556621 DOI: 10.1038/bjc.2014.30 |
0.352 |
|
| 2014 |
Ibrahim A, Barnes DR, Dunlop J, Barrowdale D, Antoniou AC, Berg JN. Attenuated familial adenomatous polyposis manifests as autosomal dominant late-onset colorectal cancer. European Journal of Human Genetics : Ejhg. 22: 1330-3. PMID 24549056 DOI: 10.1038/ejhg.2014.20 |
0.368 |
|
| 2014 |
Brohet RM, Velthuizen ME, Hogervorst FB, Meijers-Heijboer HE, Seynaeve C, Collée MJ, Verhoef S, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gómez García E, Menko F, Oosterwijk JC, Devilee P, van't Veer LJ, ... ... Antoniou AC, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. Journal of Medical Genetics. 51: 98-107. PMID 24285858 DOI: 10.1136/jmedgenet-2013-101974 |
0.564 |
|
| 2014 |
Jervis S, Song H, Lee A, Dicks E, Tyrer J, Harrington P, Easton DF, Jacobs IJ, Pharoah PP, Antoniou AC. Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants. Journal of Medical Genetics. 51: 108-13. PMID 24277755 DOI: 10.1136/jmedgenet-2013-102015 |
0.464 |
|
| 2014 |
Collins IM, Steel E, Mann GB, Emery JD, Bickerstaffe A, Trainer A, Butow P, Pirotta M, Antoniou AC, Cuzick J, Hopper J, Phillips KA, Keogh LA. Assessing and managing breast cancer risk: Clinicians' current practice and future needs Breast. 23: 644-650. DOI: 10.1016/j.breast.2014.06.014 |
0.378 |
|
| 2013 |
Keogh LA, Steel E, Emery J, Pirotta M, Mann B, Butow P, Trainer A, Moreton J, Antoniou AC, Cuzick JM, Hopper JL, Phillips KA. Assessing breast cancer risk in primary care: What can we learn from cardiovascular disease? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 17. PMID 28136574 DOI: 10.1200/jco.2013.31.26_suppl.17 |
0.409 |
|
| 2013 |
Lee AJ, Cunningham AP, Kuchenbaecker KB, Mavaddat N, Easton DF, Antoniou AC. BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. British Journal of Cancer. 110: 535-45. PMID 24346285 DOI: 10.1038/bjc.2013.730 |
0.544 |
|
| 2013 |
MacInnis RJ, Bickerstaffe A, Apicella C, Dite GS, Dowty JG, Aujard K, Phillips KA, Weideman P, Lee A, Terry MB, Giles GG, Southey MC, Antoniou AC, Hopper JL. Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre British Journal of Cancer. 109: 1296-1301. PMID 23942072 DOI: 10.1038/Bjc.2013.382 |
0.508 |
|
| 2013 |
Phillips KA, Milne RL, Rookus MA, Daly MB, Antoniou AC, Peock S, Frost D, Easton DF, Ellis S, Friedlander ML, Buys SS, Andrieu N, Noguès C, Stoppa-Lyonnet D, Bonadona V, et al. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3091-9. PMID 23918944 DOI: 10.1200/Jco.2012.47.8313 |
0.551 |
|
| 2013 |
Barnes DR, Barrowdale D, Beesley J, Chen X, James PA, Hopper JL, Goldgar D, Chenevix-Trench G, Antoniou AC, Mitchell G. Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer. British Journal of Cancer. 108: 2610-22. PMID 23756864 DOI: 10.1038/bjc.2013.277 |
0.393 |
|
| 2013 |
Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, ... ... Antoniou AC, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. Journal of the National Cancer Institute. 105: 812-22. PMID 23628597 DOI: 10.1093/jnci/djt095 |
0.57 |
|
| 2013 |
Castro E, Goh C, Olmos D, Saunders E, Leongamornlert D, Tymrakiewicz M, Mahmud N, Dadaev T, Govindasami K, Guy M, Sawyer E, Wilkinson R, Ardern-Jones A, Ellis S, Frost D, ... ... Antoniou AC, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1748-57. PMID 23569316 DOI: 10.1200/JCO.2012.43.1882 |
0.314 |
|
| 2013 |
Fischer C, Kuchenbäcker K, Engel C, Zachariae S, Rhiem K, Meindl A, Rahner N, Dikow N, Plendl H, Debatin I, Grimm T, Gadzicki D, Flöttmann R, Horvath J, Schröck E, ... ... Antoniou AC, et al. Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium. Journal of Medical Genetics. 50: 360-7. PMID 23564750 DOI: 10.1136/jmedgenet-2012-101415 |
0.513 |
|
| 2013 |
Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Antoniou AC, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212 |
0.571 |
|
| 2013 |
Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, Barrowdale D, Dunning AM, Lee A, Dennis J, Healey S, Dicks E, Soucy P, Sinilnikova OM, Pankratz VS, ... ... Antoniou AC, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. Plos Genetics. 9: e1003173. PMID 23544012 DOI: 10.1371/Journal.Pgen.1003173 |
0.578 |
|
| 2013 |
Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, ... ... Antoniou AC, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nature Genetics. 45: 385-91, 391e1-2. PMID 23535732 DOI: 10.1038/Ng.2560 |
0.361 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Antoniou AC, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.446 |
|
| 2013 |
Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R, Rodrigues DN, Renwick A, Seal S, Ramsay E, Duarte Sdel V, Rivas MA, Warren-Perry M, Zachariou A, Campion-Flora A, ... ... Antoniou AC, et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature. 493: 406-10. PMID 23242139 DOI: 10.1038/Nature11725 |
0.476 |
|
| 2013 |
Collins IM, Keogh LA, Steel E, Mann B, Emery J, Pirotta M, Moreton J, Butow P, Trainer A, Antoniou AC, Cuzick JM, Hopper JL, Phillips K. Development of a tailored, computerized, breast cancer risk assessment and decision support tool: What do clinicians want? Journal of Clinical Oncology. 31: e20660-e20660. DOI: 10.1200/JCO.2013.31.15_SUPPL.E20660 |
0.354 |
|
| 2013 |
Phillips K, Keogh LA, Steel E, Collins IM, Emery J, Pirotta M, Mann B, Butow P, Trainer A, Moreton J, Antoniou AC, Cuzick JM, Hopper JL. Assessing breast cancer risk in primary care: What can we learn from cardiovascular disease? Journal of Clinical Oncology. 31: 1559-1559. DOI: 10.1200/JCO.2013.31.15_SUPPL.1559 |
0.3 |
|
| 2012 |
Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Greene MH, Andrulis IL, Thomassen M, Caligo M, Nathanson KL, Jakubowska A, Osorio A, Hamann U, Godwin AK, Stoppa-Lyonnet D, ... ... Antoniou AC, et al. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Research and Treatment. 136: 295-302. PMID 23011509 DOI: 10.1007/S10549-012-2255-6 |
0.587 |
|
| 2012 |
Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquita HB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, ... ... Antoniou AC, et al. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). Plos One. 7: e42380. PMID 22879957 DOI: 10.1371/Journal.Pone.0042380 |
0.376 |
|
| 2012 |
Kirchhoff T, Gaudet MM, Antoniou AC, McGuffog L, Humphreys MK, Dunning AM, Bojesen SE, Nordestgaard BG, Flyger H, Kang D, Yoo KY, Noh DY, Ahn SH, Dork T, Schürmann P, et al. Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. Plos One. 7: e35706. PMID 22768030 DOI: 10.1371/journal.pone.0035706 |
0.55 |
|
| 2012 |
Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Antoniou AC, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229 |
0.558 |
|
| 2012 |
Barnes DR, Lee A, Easton DF, Antoniou AC. Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genetic Epidemiology. 36: 274-91. PMID 22714938 DOI: 10.1002/gepi.21620 |
0.399 |
|
| 2012 |
Loveday C, Turnbull C, Ruark E, Xicola RM, Ramsay E, Hughes D, Warren-Perry M, Snape K, Eccles D, Evans DG, Gore M, Renwick A, Seal S, Antoniou AC, et al. Germline RAD51C mutations confer susceptibility to ovarian cancer. Nature Genetics. 44: 475-6; author reply . PMID 22538716 DOI: 10.1038/ng.2224 |
0.379 |
|
| 2012 |
Maia AT, Antoniou AC, O'Reilly M, Samarajiwa S, Dunning M, Kartsonaki C, Chin SF, Curtis CN, McGuffog L, Domchek SM, Easton DF, Peock S, Frost D, Evans DG, et al. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R63. PMID 22513257 DOI: 10.1186/bcr3169 |
0.421 |
|
| 2012 |
Barnes DR, Antoniou AC. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. Journal of Internal Medicine. 271: 331-43. PMID 22443199 DOI: 10.1111/j.1365-2796.2011.02502.x |
0.598 |
|
| 2012 |
Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 645-57. PMID 22351618 DOI: 10.1158/1055-9965.Epi-11-0888 |
0.549 |
|
| 2012 |
Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R33. PMID 22348646 DOI: 10.1186/Bcr3121 |
0.436 |
|
| 2012 |
Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, BenÃtez J, GarcÃa MJ, ... ... Antoniou AC, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. Jama. 307: 382-90. PMID 22274685 DOI: 10.1001/Jama.2012.20 |
0.402 |
|
| 2012 |
Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human Mutation. 33: 690-702. PMID 22253144 DOI: 10.1002/Humu.22025 |
0.458 |
|
| 2012 |
Laitman Y, Kuchenbaecker KB, Rantala J, Hogervorst F, Peock S, Godwin AK, Arason A, Kirchhoff T, Offit K, Isaacs C, Schmutzler RK, Wappenschmidt B, Nevanlinna H, Chen X, Chenevix-Trench G, ... ... Antoniou AC, et al. The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 132: 1119-26. PMID 22212556 DOI: 10.1007/S10549-011-1938-8 |
0.551 |
|
| 2012 |
Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, ... ... Antoniou AC, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 134-47. PMID 22144499 DOI: 10.1158/1055-9965.Epi-11-0775 |
0.43 |
|
| 2012 |
Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, Kuligina ESh, Gorodnova TV, Pfeifer W, Togo AV, Turkevich EA, Ivantsov AO, Voskresenskiy DV, Dolmatov GD, Bit-Sava EM, ... ... Antoniou AC, et al. High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia. International Journal of Cancer. 130: 2867-73. PMID 21815139 DOI: 10.1002/ijc.26342 |
0.449 |
|
| 2012 |
Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FBL, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, ... ... Antoniou AC, et al. Association of rs12662670 with breast cancer in Asian ER Plos One. DOI: 10.1371/Journal.Pone.0042380.G006 |
0.43 |
|
| 2012 |
Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FBL, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, ... ... Antoniou AC, et al. Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) Plos One. 7. DOI: 10.1371/annotation/e5de602c-0ffc-4e6f-a2ed-f79913c2e57c |
0.443 |
|
| 2011 |
Maxwell CA, Benítez J, Gómez-Baldó L, Osorio A, Bonifaci N, Fernández-Ramires R, Costes SV, Guinó E, Chen H, Evans GJ, Mohan P, Català I, Petit A, Aguilar H, Villanueva A, ... ... Antoniou AC, et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. Plos Biology. 9: e1001199. PMID 22110403 DOI: 10.1371/Journal.Pbio.1001199 |
0.492 |
|
| 2011 |
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, ... ... Antoniou AC, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 13: R110. PMID 22053997 DOI: 10.1186/Bcr3052 |
0.533 |
|
| 2011 |
Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, ... ... Antoniou AC, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 20: 4732-47. PMID 21890493 DOI: 10.1093/Hmg/Ddr388 |
0.555 |
|
| 2011 |
Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, ... ... Antoniou AC, et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nature Genetics. 43: 879-82. PMID 21822267 DOI: 10.1038/ng.893 |
0.501 |
|
| 2011 |
Pharoah P, Antoniou A, Berchuck A, Chenevix-Trench G, Gayther S, Goode E, Milne R, Sellers T, Tyrer J. Association between KRAS rs61764370 and triple-negative breast cancer--a false positive? The Lancet. Oncology. 12: 723-4; author reply . PMID 21807336 DOI: 10.1016/S1470-2045(11)70156-5 |
0.419 |
|
| 2011 |
Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, ... Antoniou AC, et al. Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Research. 71: 5792-805. PMID 21799032 DOI: 10.1158/0008-5472.Can-11-0773 |
0.504 |
|
| 2011 |
Macinnis RJ, Antoniou AC, Eeles RA, Severi G, Al Olama AA, McGuffog L, Kote-Jarai Z, Guy M, O'Brien LT, Hall AL, Wilkinson RA, Sawyer E, Ardern-Jones AT, Dearnaley DP, Horwich A, et al. A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genetic Epidemiology. 35: 549-56. PMID 21769933 DOI: 10.1002/gepi.20605 |
0.341 |
|
| 2011 |
Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, ... ... Antoniou AC, et al. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human Genetics. 130: 685-99. PMID 21597964 DOI: 10.1007/S00439-011-1003-Z |
0.365 |
|
| 2011 |
Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 20: 3304-21. PMID 21593217 DOI: 10.1093/Hmg/Ddr226 |
0.528 |
|
| 2011 |
Garcia AI, Cox DG, Barjhoux L, Verny-Pierre C, Barnes D, Antoniou AC, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S. The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Mutation. 32: 1004-7. PMID 21591024 DOI: 10.1002/humu.21539 |
0.483 |
|
| 2011 |
Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gómez-Baldó L, Bogliolo M, Lázaro C, Blanco I, Brunet J, Aguilar H, Fernández-RodrÃguez J, Seal S, Renwick A, Rahman N, ... ... Antoniou AC, et al. Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Research : Bcr. 13: R40. PMID 21466675 DOI: 10.1186/Bcr2862 |
0.462 |
|
| 2011 |
Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson KL, Domchek SM, Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst FB, Verhoef S, van Dooren MF, Jager A, ... ... Antoniou AC, et al. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. British Journal of Cancer. 104: 1356-61. PMID 21427728 DOI: 10.1038/Bjc.2011.91 |
0.326 |
|
| 2011 |
Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H, ... ... Antoniou AC, et al. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1032-8. PMID 21393566 DOI: 10.1158/1055-9965.Epi-10-0909 |
0.574 |
|
| 2011 |
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 |
0.407 |
|
| 2011 |
Milne RL, Antoniou AC. Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. Annals of Oncology : Official Journal of the European Society For Medical Oncology. i11-7. PMID 21285145 DOI: 10.1093/annonc/mdq660 |
0.595 |
|
| 2011 |
Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, ... ... Antoniou AC, et al. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 103: 105-16. PMID 21169536 DOI: 10.1093/Jnci/Djq494 |
0.559 |
|
| 2011 |
Bolton KL, Goh C, Ramus S, Goldgar D, Benitez J, Osorio A, Easton D, Peock S, Godwin A, Kwong A, Blanco I, Goode E, Greene M, Loud J, Mai P, ... ... Antoniou A, et al. Abstract 2752: Genetic heterogeneity of ovarian cancer survival effects inBRCA1/2germline mutations: a large, multi-center study Epidemiology. 71: 2752-2752. DOI: 10.1158/1538-7445.Am2011-2752 |
0.348 |
|
| 2010 |
Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research. 70: 9742-54. PMID 21118973 DOI: 10.1158/0008-5472.Can-10-1907 |
0.555 |
|
| 2010 |
Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, Beesley J, Healey S, Chen X, Stoppa-Lyonnet D, Tirapo C, Giraud S, Mazoyer S, Muller D, ... ... Antoniou AC, et al. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 12: R102. PMID 21114847 DOI: 10.1186/Bcr2785 |
0.395 |
|
| 2010 |
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Antoniou AC, et al. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. Plos Genetics. 6: e1001183. PMID 21060860 DOI: 10.1371/Journal.Pgen.1001183 |
0.508 |
|
| 2010 |
Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans DG, Eeles R, Paterson J, Brewer C, ... ... Antoniou AC, et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2859-68. PMID 20978178 DOI: 10.1158/1055-9965.Epi-10-0517 |
0.584 |
|
| 2010 |
Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics. 42: 885-92. PMID 20852631 DOI: 10.1038/Ng.669 |
0.509 |
|
| 2010 |
Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M. Genetic susceptibility to breast cancer. Molecular Oncology. 4: 174-91. PMID 20542480 DOI: 10.1016/j.molonc.2010.04.011 |
0.528 |
|
| 2010 |
Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antoniou AC. Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Research : Bcr. 12: R28. PMID 20482762 DOI: 10.1186/bcr2576 |
0.474 |
|
| 2010 |
Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D, Sinilnikova OM, ... ... Antoniou AC, et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 19: 2886-97. PMID 20418484 DOI: 10.1093/Hmg/Ddq174 |
0.571 |
|
| 2010 |
Antoniou AC, Chenevix-Trench G. Common genetic variants and cancer risk in Mendelian cancer syndromes. Current Opinion in Genetics & Development. 20: 299-307. PMID 20399636 DOI: 10.1016/j.gde.2010.03.010 |
0.588 |
|
| 2010 |
Mavaddat N, Pharoah PD, Blows F, Driver KE, Provenzano E, Thompson D, Macinnis RJ, Shah M, Easton DF, Antoniou AC. Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Research : Bcr. 12: R10. PMID 20146796 DOI: 10.1186/bcr2476 |
0.533 |
|
| 2010 |
Spurdle AB, Fahey P, Chen X, McGuffog L, Easton D, Peock S, Cook M, Simard J, Rebbeck TR, Antoniou AC, Chenevix-Trench G. Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 122: 281-5. PMID 19921428 DOI: 10.1007/s10549-009-0601-0 |
0.58 |
|
| 2010 |
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Lubinski J. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 121: 639-49. PMID 19876733 DOI: 10.1007/s10549-009-0595-7 |
0.54 |
|
| 2010 |
MacInnis RJ, Antoniou AC, Eeles RA, Severi G, Guy M, McGuffog L, Hall AL, O'Brien LT, Wilkinson RA, Dearnaley DP, Ardern-Jones AT, Horwich A, Khoo VS, Parker CC, Huddart RA, et al. Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies. Genetic Epidemiology. 34: 42-50. PMID 19492347 DOI: 10.1002/gepi.20433 |
0.353 |
|
| 2010 |
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Antoniou AC, et al. Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer Plos Genetics. 6. DOI: 10.1371/Annotation/B28Cf02D-7196-4A16-8B36-6562A0B84F75 |
0.39 |
|
| 2010 |
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Antoniou AC, et al. Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer Plos Genetics. 6. DOI: 10.1371/annotation/59ea8540-4e63-4f4a-a79e-f68765fdeac7 |
0.473 |
|
| 2009 |
Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S, Neuhausen SL, Ding YC, Couch FJ, ... ... Antoniou AC, et al. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). British Journal of Cancer. 101: 2048-54. PMID 19920816 DOI: 10.1038/Sj.Bjc.6605416 |
0.573 |
|
| 2009 |
Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, et al. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 101: 1456-60. PMID 19707196 DOI: 10.1038/Sj.Bjc.6605279 |
0.484 |
|
| 2009 |
Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Neuhausen SL, Ding YC, Couch FJ, Wang X, et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 18: 4442-56. PMID 19656774 DOI: 10.1093/Hmg/Ddp372 |
0.537 |
|
| 2009 |
Kataoka M, Antoniou A, Warren R, Leyland J, Brown J, Audley T, Easton D. Genetic models for the familial aggregation of mammographic breast density. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1277-84. PMID 19336563 DOI: 10.1158/1055-9965.EPI-08-0568 |
0.397 |
|
| 2009 |
Antoniou AC, Rookus M, Andrieu N, Brohet R, Chang-Claude J, Peock S, Cook M, Evans DG, Eeles R, Nogues C, Faivre L, Gesta P, van Leeuwen FE, et al. Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 601-10. PMID 19190154 DOI: 10.1158/1055-9965.EPI-08-0546 |
0.49 |
|
| 2009 |
Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen X, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek SM, ... ... Antoniou AC, et al. No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Research and Treatment. 117: 371-9. PMID 19082709 DOI: 10.1007/S10549-008-0257-1 |
0.506 |
|
| 2009 |
Spurdle AB, Deans AJ, Duffy D, Goldgar DE, Chen X, Beesley J, Easton DF, Antoniou AC, Peock S, Cook M, Nathanson KL, Domchek SM, MacArthur GA, Chenevix-Trench G. No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers Breast Cancer Research and Treatment. 115: 307-313. PMID 18543099 DOI: 10.1007/S10549-008-0083-5 |
0.543 |
|
| 2009 |
Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB, Couch FJ, Pereira LH, Greene MH, Andrulis IL, Pasche B, Kaklamani V, et al. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Research and Treatment. 115: 185-92. PMID 18523885 DOI: 10.1007/S10549-008-0064-8 |
0.495 |
|
| 2008 |
Osorio A, Pollán M, Pita G, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Preisler-Adams S, Niederacher D, Hofmann W, Gadzicki D, Jakubowska A, Hamann U, Lubinski J, ... ... Antoniou AC, et al. An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 99: 974-7. PMID 18781154 DOI: 10.1038/Sj.Bjc.6604624 |
0.506 |
|
| 2008 |
Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. The New England Journal of Medicine. 358: 2796-803. PMID 18579814 DOI: 10.1056/NEJMsa0708739 |
0.4 |
|
| 2008 |
Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Díez O, Alonso MC, Lazaro C, Blanco I, Sánchez-de-Abajo A, Caldés T, Blanco A, Graña B, Durán M, ... ... Antoniou AC, et al. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2861-9. PMID 18451254 DOI: 10.1158/1078-0432.CCR-07-4436 |
0.513 |
|
| 2008 |
Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, et al. Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. Journal of Medical Genetics. 45: 425-31. PMID 18413374 DOI: 10.1136/jmg.2007.056556 |
0.354 |
|
| 2008 |
Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. American Journal of Human Genetics. 82: 937-48. PMID 18355772 DOI: 10.1016/J.Ajhg.2008.02.008 |
0.564 |
|
| 2008 |
Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. British Journal of Cancer. 98: 1457-1466. PMID 18349832 DOI: 10.1038/Sj.Bjc.6604305 |
0.569 |
|
| 2008 |
Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: Updates and extensions (British Journal of Cancer (2008) 98, (1457-1466) DOI: 10.1038/sj.bjc.6604305) British Journal of Cancer. 98: 2015. DOI: 10.1038/Sj.Bjc.6604411 |
0.464 |
|
| 2008 |
Sinilnikova O, Antoniou A, Spurdle A, Healey S, Schmutzler R, Neuhausen S, Couch F, Stoppa-Lyonnet D, Chenevix-Trench G, Easton D. Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers European Journal of Cancer Supplements. 6: 207-208. DOI: 10.1016/S1359-6349(08)71913-X |
0.566 |
|
| 2007 |
Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. American Journal of Human Genetics. 81: 1186-200. PMID 17999359 DOI: 10.1086/522611 |
0.498 |
|
| 2007 |
Domchek SM, Antoniou A. Cancer risk models: translating family history into clinical management. Annals of Internal Medicine. 147: 515-7. PMID 17909212 DOI: 10.7326/0003-4819-147-7-200710020-00009 |
0.336 |
|
| 2007 |
Brohet RM, Goldgar DE, Easton DF, Antoniou AC, Andrieu N, Chang-Claude J, Peock S, Eeles RA, Cook M, Chu C, Noguès C, Lasset C, Berthet P, Meijers-Heijboer H, Gerdes AM, et al. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3831-6. PMID 17635951 DOI: 10.1200/JCO.2007.11.1179 |
0.539 |
|
| 2007 |
Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, ... ... Antoniou AC, et al. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1416-21. PMID 17627006 DOI: 10.1158/1055-9965.EPI-07-0129 |
0.568 |
|
| 2007 |
Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Research : Bcr. 9: 104. PMID 17466083 DOI: 10.1186/bcr1670 |
0.577 |
|
| 2007 |
Chang-Claude J, Andrieu N, Rookus M, Brohet R, Antoniou AC, Peock S, Davidson R, Izatt L, Cole T, Noguès C, Luporsi E, Huiart L, Hoogerbrugge N, Van Leeuwen FE, Osorio A, et al. Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study Cancer Epidemiology Biomarkers and Prevention. 16: 740-746. PMID 17416765 DOI: 10.1158/1055-9965.EPI-06-0829 |
0.54 |
|
| 2007 |
Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Chang-Claude J. Response: Re: Pregnancies, Breastfeeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) Jnci Journal of the National Cancer Institute. 99: 1131-1131. DOI: 10.1093/JNCI/DJM041 |
0.486 |
|
| 2006 |
Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, Easton DF, Evans DG. Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 8: R72. PMID 17187672 DOI: 10.1186/bcr1630 |
0.553 |
|
| 2006 |
Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene. 25: 5898-905. PMID 16998504 DOI: 10.1038/sj.onc.1209879 |
0.536 |
|
| 2006 |
Antoniou AC, Pharoah PD, Easton DF, Evans DG. BRCA1 and BRCA2 cancer risks. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3312-3; author reply. PMID 16829658 DOI: 10.1200/JCO.2006.06.7934 |
0.521 |
|
| 2006 |
Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, Antoniou AC, Wagner T, Simard J, Evans G, Peock S, Fricker JP, Nogues C, Veer LV, Leeuwen FEV, et al. Effect of Chest X-Rays on the Risk of Breast Cancer Among BRCA1/2 Mutation Carriers in the International BRCA1/2 Carrier Cohort Study: A Report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ Group Journal of Clinical Oncology. 24: 3361-3366. PMID 16801631 DOI: 10.1200/Jco.2005.03.3126 |
0.436 |
|
| 2006 |
Lalloo F, Varley J, Moran A, Ellis D, O'dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DG. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. European Journal of Cancer (Oxford, England : 1990). 42: 1143-50. PMID 16644204 DOI: 10.1016/j.ejca.2005.11.032 |
0.517 |
|
| 2006 |
Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Peock S, Evans G, Eccles D, Douglas F, Noguès C, Gauthier-Villars M, Chompret A, Leeuwen FEV, Kluijt I, et al. Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) Journal of the National Cancer Institute. 98: 535-544. PMID 16622123 DOI: 10.1093/Jnci/Djj132 |
0.551 |
|
| 2006 |
Antoniou AC, Easton DF. Risk prediction models for familial breast cancer. Future Oncology (London, England). 2: 257-74. PMID 16563094 DOI: 10.2217/14796694.2.2.257 |
0.534 |
|
| 2006 |
Mitchell G, Antoniou AC, Warren R, Peock S, Brown J, Davies R, Mattison J, Cook M, Warsi I, Evans DG, Eccles D, Douglas F, Paterson J, Hodgson S, Izatt L, et al. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Research. 66: 1866-72. PMID 16452249 DOI: 10.1158/0008-5472.CAN-05-3368 |
0.522 |
|
| 2006 |
Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, et al. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 76-9. PMID 16434590 DOI: 10.1158/1055-9965.Epi-05-0709 |
0.559 |
|
| 2005 |
Ponder BAJ, Antoniou A, Dunning A, Easton DF, Pharoah PDP. Polygenic inherited predisposition to breast cancer Cold Spring Harbor Symposia On Quantitative Biology. 70: 35-41. PMID 16869736 DOI: 10.1101/sqb.2005.70.029 |
0.507 |
|
| 2005 |
Antoniou AC, Durocher F, Smith P, Simard J, Easton DF. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Research : Bcr. 8: R3. PMID 16417652 DOI: 10.1186/bcr1365 |
0.514 |
|
| 2005 |
Antoniou AC, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: A combined analysis of 22 population based studies Journal of Medical Genetics. 42: 602-603. PMID 15994883 DOI: 10.1136/Jmg.2004.024133 |
0.504 |
|
| 2005 |
Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, et al. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France. Genes, Chromosomes & Cancer. 43: 404-13. PMID 15887246 DOI: 10.1002/gcc.20199 |
0.474 |
|
| 2005 |
Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, et al. Two ATM variants and breast cancer risk. Human Mutation. 25: 594-5. PMID 15880680 DOI: 10.1002/Humu.9344 |
0.331 |
|
| 2005 |
Spurdle AB, Antoniou AC, Duffy DL, Pandeya N, Kelemen L, Chen X, Peock S, Cook MR, Smith PL, Purdie DM, Newman B, Dite GS, Apicella C, Southey MC, Giles GG, et al. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 7: R176-83. PMID 15743497 DOI: 10.1186/bcr971 |
0.489 |
|
| 2005 |
Hartikainen JM, Tuhkanen H, Kataja V, Dunning AM, Antoniou A, Smith P, Arffman A, Pirskanen M, Easton DF, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: three candidate regions found. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 75-80. PMID 15668479 |
0.492 |
|
| 2005 |
Antoniou AC, Durocher F, Smith P, Simard J, Easton DF, Bessette P, Bridge P, Chiquette J, Ptovencher L, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Voyer P. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families Breast Cancer Research. 8. DOI: 10.1186/bcr1365 |
0.488 |
|
| 2005 |
Antoniou AC, Pharoah PDP, Cunningham AP, Easton DF. Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK British Journal of Cancer. 92: 1337-1338. DOI: 10.1038/sj.bjc.6602488 |
0.433 |
|
| 2004 |
Easton DF, Hopper JL, Thomas DC, Antoniou A, Pharoah PDP, Whittemore AS, Haile RW. Breast cancer risks for BRCA1/2 carriers. Science. 306: 2187-2191. PMID 15622557 DOI: 10.1126/Science.306.5705.2187C |
0.549 |
|
| 2004 |
Antoniou AC, Pharoah PP, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. British Journal of Cancer. 91: 1580-90. PMID 15381934 DOI: 10.1038/sj.bjc.6602175 |
0.549 |
|
| 2004 |
Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: Implications for design of association studies. Genetic Epidemiology. 25: 190-202. PMID 14557987 DOI: 10.1002/GEPI.10261 |
0.371 |
|
| 2003 |
Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies American Journal of Human Genetics. 72: 1117-1130. PMID 12677558 DOI: 10.1086/375033 |
0.565 |
|
| 2002 |
Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Human Molecular Genetics. 11: 1399-407. PMID 12023982 DOI: 10.1093/HMG/11.12.1399 |
0.501 |
|
| 2002 |
Pharoah PDP, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BAJ. Polygenic susceptibility to breast cancer and implications for prevention Nature Genetics. 31: 33-36. PMID 11984562 DOI: 10.1038/ng853 |
0.441 |
|
| 2002 |
Antoniou AC, Pharoah PDP, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes British Journal of Cancer. 86: 76-83. PMID 11857015 DOI: 10.1038/sj.bjc.6600008 |
0.556 |
|
| 2001 |
Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genetic Epidemiology. 21: 1-18. PMID 11443730 DOI: 10.1002/gepi.1014 |
0.504 |
|
| 2000 |
Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MR, Hopper JL. After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. American Journal of Human Genetics. 68: 420-31. PMID 11133358 DOI: 10.1086/318187 |
0.551 |
|
| 2000 |
Antoniou AC, Gayther SA, Stratton JF, Ponder BA, Easton DF. Risk models for familial ovarian and breast cancer. Genetic Epidemiology. 18: 173-90. PMID 10642429 DOI: 10.1002/(SICI)1098-2272(200002)18:2<173::AID-GEPI6>3.0.CO;2-R |
0.543 |
|
| 2000 |
Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA. The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. American Journal of Human Genetics. 65: 1021-9. PMID 10486320 DOI: 10.1086/302583 |
0.407 |
|
| 1999 |
ANTONIOU AC, EASTON DF, GAYTHER SA, STRATTON JF, PONDER BJ. Risk Models for Familial Breast and Ovarian Cancer Annals of Human Genetics. 63: 351-351. DOI: 10.1046/J.1469-1809.1999.63403511.X |
0.503 |
|
| Show low-probability matches. |